Blood test may improve survival of childhood cancer in Africa

Published on March 19, 2026

A simple blood test could speed up diagnosis and improve outcomes for children with Africa’s most common childhood cancer.
Continue reading on website
Other news

Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment

March 19, 2026
Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.

2026 UK Innovation Report finds UK excels in early-stage innovation but underperforms on innovation outcomes

March 20, 2026
The UK is one of the world’s leading innovation economies. It ranks fourth globally for scientific publications (behind only China, the USA, and India) and sits among the top countries for high-impact research and patents in critical technologies. It has also built one of the strongest startup ecosystems outside the United States. The latest UK Innovation Report finds that while the UK excels in r